Bosh sahifaONCY • NASDAQ
add
Oncolytics Biotech Inc
1,01 $
Seans yopilganidan keyin:(2,05%)-0,021
0,99 $
Yopilgan:22-avg, 20:00:00 (GMT-4) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
1,01 $
Kunlik diapazon
0,99 $ - 1,05 $
Yillik diapazon
0,33 $ - 1,53 $
Bozor kapitalizatsiyasi
88,76 mln USD
Oʻrtacha hajm
867,83 ming
Narx/foyda
-
Dividend daromadliligi
-
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (CAD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | — | — |
Joriy xarajat | 5,71 mln | -27,95% |
Sof foyda | -6,16 mln | 15,04% |
Sof foyda marjasi | — | — |
Har bir ulushga tushum | -0,07 | 28,86% |
EBITDA | -5,68 mln | 28,02% |
Amaldagi soliq stavkasi | -1,40% | — |
Balans
Jami aktivlari
Jami passivlari
| (CAD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 14,63 mln | -41,14% |
Jami aktivlari | 19,97 mln | -37,72% |
Jami passivlari | 13,88 mln | 0,92% |
Umumiy kapital | 6,09 mln | — |
Tarqatilgan aksiyalar | 100,36 mln | — |
Narxi/balansdagi bahosi | 16,83 | — |
Aktivlardan daromad | -71,91% | — |
Kapitaldan daromad | -197,15% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (CAD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -6,16 mln | 15,04% |
Operatsiyalardan naqd pul | -5,47 mln | 19,77% |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | 5,37 mln | 172,05% |
Naqd pulning sof oʻzgarishi | -677,00 ming | 85,76% |
Boʻsh pul | -3,25 mln | 28,13% |
Haqida
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that: induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
Tashkil etilgan
1998
Bosh ofis
Xodimlar soni
28
